In the current studies, a DNA vaccine administered by intramuscular electroporation with a construct fusing MIP3α to the melanoma tumor-associated antigen gp100 has been analyzed in a therapeutic vaccination protocol utilizing the B16F10 melanoma mouse model system. The gene discussed is CCL20; the disease is melanoma.